Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

How to compensate for frailty? The real life impact of geriatric co-management on morbi-mortality after colorectal cancer surgery in patients aged 70 years or older.

Aging clinical and experimental research·2024
Same author

Comprehensive analysis of synthetic learning applied to neonatal brain MRI segmentation.

Human brain mapping·2024
Same author

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same journal

Generative morphodynamic forecasting enables robust zero-shot volumetric medical segmentation.

Medical image analysis·2026
Same journal

ContiMorph: An unsupervised learning framework for cardiac motion tracking with time-continuous diffeomorphism.

Medical image analysis·2026
Same journal

MedP-CLIP: Medical CLIP with region-aware prompt integration.

Medical image analysis·2026
Same journal

Multi-organ guided diagnosis of mild cognitive impairment via hierarchical alignment and knowledge distillation.

Medical image analysis·2026
Same journal

SUDA: Simultaneous unsupervised knowledge distillation and adaptation of foundation models for efficient pathological image analysis.

Medical image analysis·2026
Same journal

Beyond the LUMIR challenge: The pathway to foundational registration models.

Medical image analysis·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

Evaluation of brain atrophy estimation algorithms using simulated ground-truth data.

S Sharma1, V Noblet, F Rousseau

  • 1Laboratoire d'Imagerie et de Neurosciences Cognitives (LINC-UDS) FRE 3289, CNRS, Strasbourg, France. swati.sharma@linc.u-strasbg.fr

Medical Image Analysis
|March 12, 2010
PubMed
Summary
This summary is machine-generated.

This study introduces a novel method for simulating brain tissue loss to create gold standards for validating brain atrophy estimation tools. Results show bias-field inhomogeneity and noise significantly impact accuracy in methods like SIENA, SIENAX, and BSI-UCD.

More Related Videos

Three-Dimensional Shape Modeling and Analysis of Brain Structures
05:33

Three-Dimensional Shape Modeling and Analysis of Brain Structures

Published on: November 14, 2019

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
06:48

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jun 15, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

Three-Dimensional Shape Modeling and Analysis of Brain Structures
05:33

Three-Dimensional Shape Modeling and Analysis of Brain Structures

Published on: November 14, 2019

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
06:48

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images

Published on: January 7, 2019

Area of Science:

  • Neuroimaging
  • Medical Image Analysis
  • Computational Anatomy

Background:

  • Brain atrophy is a key marker for neurodegenerative diseases like Alzheimer's and Multiple Sclerosis.
  • Validating MRI-based brain atrophy estimation tools is crucial but challenging due to the lack of gold standards.
  • Existing tools require rigorous evaluation for clinical application.

Purpose of the Study:

  • To develop a realistic simulation approach for generating gold standards of brain tissue loss.
  • To evaluate the performance and robustness of standard brain atrophy estimation methods (SIENA, SIENAX, BSI-UCD).
  • To assess the impact of various error sources on atrophy estimation accuracy.

Main Methods:

  • Realistic simulation of brain tissue loss using topology-preserving B-spline deformation fields.
  • Creation of gold standards for quantitative comparison.
  • Performance evaluation of SIENA, SIENAX, and BSI-UCD against simulated data.
  • Analysis of robustness to bias-field inhomogeneity, noise, geometrical distortions, interpolation artifacts, and lesions.

Main Results:

  • Bias-field inhomogeneity and noise were identified as major sources of error in atrophy estimation.
  • Simulated whole brain atrophies (0.2-1.5%) revealed mean errors in the presence of noise and inhomogeneity.
  • SIENA, SIENAX, and BSI-UCD showed mean errors of 0.64±0.53%, 4.00±2.41%, and 1.79±0.97%, respectively.

Conclusions:

  • The proposed simulation method provides reliable gold standards for validating brain atrophy estimation techniques.
  • The study highlights the significant impact of image artifacts, particularly bias-field inhomogeneity and noise, on the accuracy of current atrophy measurement tools.
  • Findings guide the selection and improvement of neuroimaging analysis tools for clinical use in neurodegenerative disease research.